Drug profile · INN
pacritinib citrate
VONJO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pacritinib citrate (VONJO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pacritinib citrate
Brand VONJO
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is pacritinib citrate?
pacritinib citrate (VONJO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pacritinib citrate?
VONJO is a marketed brand name for pacritinib citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pacritinib citrate?
pacritinib citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.